Since α-2,6-sialilation is often correlated with increased tumor invasiveness, the transfer of ST6Gal1 and other glycosylation-related enzymes may be yet another mechanism by which EVs promote cancer progression. This evidence concerns the gene ST6GAL1 and neoplasm.